2024-12-19 - Analysis Report
## UnitedHealth Group Inc. (UNH) Investment Report

**1. Performance Summary & Comparison to S&P 500 (VOO):**

UnitedHealth Group Inc. (UNH) is a diversified healthcare company offering a range of products and services.  Over the period analyzed, UNH significantly outperformed the S&P 500 (VOO).  The cumulative return for UNH is 131.6%, while VOO's is 114.4%.  This represents a difference of 17.2 percentage points.  The relative divergence of 15.3% indicates UNH's performance is in the upper range of its historical performance relative to the S&P 500.  However, note that this is a relative measure based on the historical range and doesn't predict future performance.

The provided CAGR data shows consistently high growth for UNH (52% to 102%) from 2015 to 2022, exceeding that of the S&P 500, although the most recent period (2022-2024) shows a substantial negative CAGR (-27%).  Alpha consistently remains positive, suggesting outperformance relative to the market benchmark.  Beta is significantly higher than 1, indicating higher volatility than the overall market.

**2. Recent Price Movement:**

* **Closing Price:** $499.72
* **5-Day Moving Average:** $503.996
* **20-Day Moving Average:** $566.2551
* **60-Day Moving Average:** $575.4733

The current price is below all three moving averages, suggesting a downward trend in the short to medium term.

**3. Technical Indicators & Expected Return:**

* **RSI (22.62):**  Indicates the stock is currently in oversold territory, potentially suggesting a bounce back is possible, but it doesn't guarantee a price increase.
* **PPO (-1.91):**  Negative value shows a bearish momentum.
* **20-Day Relative Divergence (-5.7%):**  A recent downward trend.
* **Expected Return (436.4%):**  This represents a very high projected return over the long term (2+ years) relative to the S&P 500. This forecast should be treated with caution due to the inherent uncertainties in long-term market predictions.  The given number is substantial and may not accurately reflect realistic long-term expectations.

The current price of $499.72, while below its recent moving averages, doesn't necessarily signal a significant price drop.  However, the combination of low RSI and negative PPO, coupled with the downward trend, warrants caution.

**4. Recent Earnings Analysis:**

The provided earnings data reveals some inconsistencies and potential errors (duplicate entry for 2024-11-04).  Assuming the duplicate entry is corrected, here's an analysis based solely on the unique data points:

* **Quarterly Comparison:**  EPS shows significant fluctuation, with Q3 2024 displaying a substantial drop compared to Q4 2023 and Q2 2024.  Revenue remains relatively stable, although there is some fluctuation.
* **Revenue Growth Trends:**  Overall revenue growth shows a slight increase over the period but not necessarily consistent growth quarter to quarter.
* **EPS Trends:**  The EPS shows significant volatility, with a considerable negative EPS in Q2 2024.
* **Beats/Misses:** The provided data lacks information about earnings expectations, so it's impossible to assess whether results were beats or misses.

**Further data analysis is required to draw stronger conclusions.**  Without having access to the expected values (analysts' estimates), a comprehensive earnings analysis cannot be performed. The inconsistency within the data also raises concern regarding its accuracy.


**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue has remained relatively stable over the past year, hovering around the $98B mark. Profit margins have shown some fluctuations, ranging from 21.52% to 24.51%, although it shows a decline over the recent periods.

* **Capital and Profitability:** Equity increased generally but shows some slight fluctuations quarter to quarter.  ROE also shows considerable volatility, even dipping into negative territory in Q1 2024.  This suggests significant fluctuations in profitability.


**6. News and Recent Issues:**

This section requires information not provided in the prompt. To complete this analysis, recent news articles and analyst reports on UNH would need to be consulted.

**7. Overall Analysis:**

UNH has historically outperformed the S&P 500, but recent trends suggest a potential slowdown. The company shows considerable volatility in both price and earnings. While the long-term expected return is exceptionally high, it's crucial to exercise caution given the present downward trend, negative PPO, low RSI,  and the volatility shown across both revenue and profit numbers.   More detailed analysis of earnings against expectations, as well as a review of recent news and analyst sentiment, is essential before making any investment decisions.  The provided data raises several concerns regarding data integrity and consistency that needs to be addressed prior to confident analysis.


**8. Disclaimer:**  This report is for informational purposes only and does not constitute financial advice.  The information provided is based on the limited data supplied and should not be the sole basis for investment decisions.  Conduct thorough due diligence and consult with a qualified financial advisor before making any investment choices.
